Abstract:A series of mono-and bisnaphthalimides derivatives containing 3-nitro and 4-morpholine moieties were designed, synthesized, and evaluated for their in vitro anticancer activities against four cancer cell lines. Some compounds exhibited relatively good antiproliferative activity on the cell lines tested, in comparison with mitonafide and amonafide. It is noteworthy that bisnaphthalimide A6 was identified as the most potent com-pound in anti-proliferation against MGC-803 cells, with an IC50 lowered to 0.09 mu M, a far greater potency than that of mono-naphthalimide A7, mitonafide, and amonafide. A gel electrophoresis assay revealed that DNA and Topo I were the potential targets of compounds A6 and A7. The treatment of CNE-2 cells with compounds A6 and A7 resulted in an S phase cell cycle arrest, accompanied by the upregulation of the expression levels of the antioncogene p27 and the down-regulation of the expression levels of CDK2 and cyclin E. In addition, compounds A6 and A7-induced apoptosis was further confirmed by flow cytometry, ROS generation assay, and Hoechst 33,258 staining. In particular, in vivo antitumor assay results revealed that bisnaphthalimide A6 exhibited potent anticancer efficiency in an MGC-803 xenograft tumor model, in comparison with mitonafide, and had lower toxicity than mono-naphthalimide A7. In brief, the results suggested that bisnaphthalimide derivatives con-taining 3-nitro and 4-morpholine moieties might serve as DNA binding agents for the development of new antitumor agents.

Design of Β-Carboline Derivatives As DNA-targeting Antitumor Agents

Synthesis and in Vitro Antitumor Activity of Novel Bivalent Β-Carboline-3-carboxylic Acid Derivatives with DNA As a Potential Target

Synthesis and biological evaluation of 1,9-disubstituted β-carbolines as potent DNA intercalating and cytotoxic agents.

Synthesis, cytotoxic activities and DNA binding properties of β-carboline derivatives.

Design, synthesis and mechanism of action of novel 1,9-disubstituted beta-carboline derivatives as antitumor agents

Synthesis And Biological Evaluation Of Novel Beta-Carbolines As Potent Cytotoxic And Dna Intercalating Agents

Design, synthesis and 3D-QSAR of β-carboline derivatives as potent antitumor agents

Synthesis and in Vitro Cytotoxic Evaluation of Novel 3,4, 5-Trimethoxyphenyl Substituted Beta-Carboline Derivatives

Synthesis of Novel Beta-Carbolines with Efficient Dna-Binding Capacity and Potent Cytotoxicity

Design, Synthesis and Pharmacological Evaluation of Β-Carboline Derivatives As Potential Antitumor Agent Via Targeting Autophagy

Design, Synthesis, and Biological Evaluation of Novel Γ-Carboline Ketones As Anticancer Agents

Design, Synthesis, and Antitumor Activity of Β-Carboline- Benzimidazole Hybrids

Synthesis and Antitumor Activities of Β-Carboline Derivatives

Synthesis and antitumor activity of novel N-substituted tetrahydro-β-carboline-imidazolium salt derivatives.

Design, Synthesis, and Antitumor Evaluation of Morpholine Substituted Bisnaphthalimides As DNA Targeting Agents.

Design, Synthesis and in vitro Antitumor Activities of Novel Bivalent beta-Carbolines

Discovery of Novel Heteroarylmethylcarbamodithioates As Potent Anticancer Agents: Synthesis, Structure-Activity Relationship Analysis and Biological Evaluation.

Synthesis and Cytotoxic Activities of Beta-Carboline Amino Acid Ester Conjugates

Synthesis and biological evaluation of a novel class of beta-carboline derivatives

Design, Synthesis and Biological Activity Evaluation of β-Carboline Derivatives Containing Nitrogen Heterocycles

Design, Synthesis and in Vitro Antitumor Activities of Novel Bivalent Β-Carbolines